MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich’s Ascites Tumor in Mice
Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich’s Ascites Tumor in Mice
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich’s Ascites Tumor in Mice
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich’s Ascites Tumor in Mice
Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich’s Ascites Tumor in Mice

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich’s Ascites Tumor in Mice
Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich’s Ascites Tumor in Mice
Journal Article

Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich’s Ascites Tumor in Mice

2015
Request Book From Autostore and Choose the Collection Method
Overview
Dietary energy restriction (DER) has been well established as a potent anticancer strategy. Non-adoption of restricted diet for an extended period has limited its practical implementation in humans with a compelling need to develop agents that mimic effects similar to DER, without reduction in actual dietary intake. Glycolytic inhibitor, 2-deoxy-D-glucose (2-DG), has recently been shown to possess potential as an energy restriction mimetic agent (ERMA). In the present study we evaluated the effect of dietary 2-DG administration on a mouse tumor model, with a focus on several potential mechanisms that may account for the inhibition of tumorigenesis. Swiss albino strain 'A' mice were administered with 0.2% and 0.4% w/v 2-DG in drinking water for 3 months prior to tumor implantation (Ehrlich's ascites carcinoma; EAC) and continued till the termination of the study with no adverse effects on general physiology and animal growth. Dietary 2-DG significantly reduced the tumor incidence, delayed the onset, and compromised the tumor growth along with enhanced survival. We observed reduced blood glucose and serum insulin levels along with decreased proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine positive (BrdU+) tumor cells in 2-DG fed mice. Also, reduced levels of certain key players of metabolic pathways such as phosphatidylinositol 3-kinase (PI3K), phosphorylated-Akt and hypoxia inducible factor-1 alpha (HIF-1α) were also noted in tumors of 2-DG fed mice. Further, decrease in CD4+/CD8+ ratio and T-regulatory cells observed in 2-DG fed mice suggested enhanced antitumor immunity and T cell effector function. These results strongly suggest that dietary 2-DG administration in mice, at doses easily achievable in humans, suitably modulates several pleotrophic factors mimicking DER and inhibits tumorigenesis, emphasizing the use of ERMAs as a promising cancer preventive strategy.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject

1-Phosphatidylinositol 3-kinase

/ Aging

/ AKT protein

/ Analysis

/ Angiogenesis

/ Animal growth

/ Animals

/ Antimetabolites, Antineoplastic - administration & dosage

/ Antimetabolites, Antineoplastic - blood

/ Antimetabolites, Antineoplastic - pharmacology

/ Antimetabolites, Antineoplastic - therapeutic use

/ Antineoplastic agents

/ Ascites

/ Biomedical research

/ Biotechnology

/ Blood glucose

/ Blood Glucose - analysis

/ Brain cancer

/ Bromodeoxyuridine

/ Caloric Restriction

/ Cancer therapies

/ Carcinoma, Ehrlich Tumor - blood supply

/ Carcinoma, Ehrlich Tumor - drug therapy

/ Carcinoma, Ehrlich Tumor - immunology

/ CD4 antigen

/ CD4-CD8 Ratio

/ CD8 antigen

/ Cell cycle

/ Cell Division - drug effects

/ Cytotoxicity

/ Deoxyglucose - administration & dosage

/ Deoxyglucose - blood

/ Deoxyglucose - pharmacology

/ Deoxyglucose - therapeutic use

/ Diet

/ Dietary intake

/ Dietary restrictions

/ Drinking water

/ Drug Screening Assays, Antitumor

/ Energy

/ Female

/ Glucose

/ Glycolysis

/ Glycolysis - drug effects

/ Growth

/ Hypoxia

/ Immunity

/ Immunoregulation

/ Implantation

/ Inhibitors

/ Insulin

/ Insulin - blood

/ Insulin-like growth factors

/ Ionizing radiation

/ Kinases

/ Laboratories

/ Lymphocytes

/ Lymphocytes T

/ Matrix Metalloproteinase 9 - analysis

/ Metabolic pathways

/ Metabolism

/ Mice

/ Mimicry

/ Neoplasm Proteins - physiology

/ Neovascularization, Pathologic - drug therapy

/ Nuclear medicine

/ Physiological aspects

/ Premedication

/ Proliferating cell nuclear antigen

/ Prostate

/ Random Allocation

/ Rodents

/ Signal transduction

/ Signal Transduction - drug effects

/ T cells

/ T-Lymphocytes, Regulatory - drug effects

/ T-Lymphocytes, Regulatory - immunology

/ Tumor Burden - drug effects

/ Tumor cells

/ Tumorigenesis

/ Tumors